Singapore proposes changes to patents regime
Practitioners have welcomed Intellectual Property Office of Singapore (IPOS) amendments to the patent regime to spur innovation and improve the quality of patents granted
One of the package’s most important steps is to
follow decisions in the landmark cases of Association for
Molecular Pathology v Myriad Genetics, from the US, and
Australia’s D'Arcy v Myriad Genetics by clarifying
that Singapore believes isolating DNA in...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.